Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,436,970 papers from all fields of science
Search
Sign In
Create Free Account
Thombran
Known as:
Boehringer Ingelheim Brand of Trazodone Hydrochloride
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Trazodone
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
SAT0305 ASSOCIATION OF SKIN PSORIASIS WITH CLINICAL AND RADIOGRAPHIC CHARACTERISTICS IN AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORT
M. Protopopov
,
F. Proft
,
J. Sieper
,
H. Haibel
,
M. Rudwaleit
,
D. Poddubnyy
Saturday, 15 June
2019
Corpus ID: 190889700
Background: Overlap between psoriasis and axial spondyloarthritis (axSpA) is common, as psoriasis occurs in approximately 10% of…
Expand
Review
2017
Review
2017
Cyclic Neutropenia, Congenital and Idiopathic Neutropenia
D. Dale
,
A. Bolyard
,
J. Leung
,
E. Tran
,
Tracy M. Marrero
,
P. Newburger
2017
Corpus ID: 201168737
Background: Cyclic neutropenia (CyN) is an autosomal dominant disease usually attributable to mutations in the gene for…
Expand
2016
2016
Seminal Vesiculitis in Three Pet Rabbits ( Oryctolagus cuniculus ).
M. Ardiaca
,
C. Bonvehí
,
M. Cuesta
,
Alicia Gómez
,
A. Montesinos
The Journal of the American Animal Hospital…
2016
Corpus ID: 28884989
To date, descriptions of pathologic conditions of the seminal vesicle in rabbits are scarce and limited to the laboratory animals…
Expand
Review
2015
Review
2015
Novel angiogenesis inhibitors in nonsmall cell lung cancer
N. Reinmuth
,
D. Heigener
,
M. Reck
Current Opinion in Oncology
2015
Corpus ID: 24413841
Purpose of review The fact that growth and spread of tumours are dependent on angiogenesis has led to the investigation of the…
Expand
Review
2010
Review
2010
BI-10773, a sodium-glucose cotransporter 2 inhibitor for the potential oral treatment of type 2 diabetes mellitus.
I. Aires
,
J. Calado
Current opinion in investigational drugs
2010
Corpus ID: 20852904
BI-10773, being developed by Boehringer Ingelheim Corp, is a sodium-glucose cotransporter (SGLT)2 inhibitor for the oral…
Expand
Review
2009
Review
2009
Linagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes.
A. Tiwari
Current opinion in investigational drugs
2009
Corpus ID: 46370241
Boehringer Ingelheim Corp is developing the novel, xanthine-based dipeptidyl peptidase (DPP)-4 inhibitor linagliptin for the…
Expand
2006
2006
Theoretical investigation of the behavior of titratable groups in proteins
Astrid R. Klingen
,
E. Bombarda
,
G. Matthias Ullmann
Photochemical and Photobiological Sciences
2006
Corpus ID: 24934583
This paper presents a theoretical analysis of the titration behavior of strongly interacting titratable residues in proteins…
Expand
Review
2004
Review
2004
Reliability , fairness and predictive validity of committee peer review Evaluation of the selection of post-graduate fellowship holders by the Boehringer Ingelheim Fonds
L. Bornmann
,
Hans-Dieter Daniel
2004
Corpus ID: 7602301
In science, peer review is the oldest and best established method of assessing manuscripts, applications for research fellowships…
Expand
1939
1939
Untersuchungen über die spasmolytische Wirkung von Restalkaloiden aus der Lobelia inflata usw
R. Richter
Naunyn-Schmiedebergs Archiv für Experimentelle…
1939
Corpus ID: 41661668
Her r Dr. T h o m ~ im wissenschaft l ichen L a b o r a t o r i u m der Chemisehen Fabr ik C. H. B o e h r i n g e r , Nieder…
Expand
1936
1936
Über Narkotolin, ein neues Alkaloid aus Mohn (Papaver somniferum)
F. Wrede
Naunyn-Schmiedebergs Archiv für Experimentelle…
1936
Corpus ID: 39812064
In den letzten Jahren ist aus wirtschaftlichen Grfinden versueht worden, den Bedarf an Mohnalkaloiden nieht aus Opium zu decken…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE